Introduction
Urinary tract infection in women is among the most common infections encountered in the Accident & Emergency Department (AED). There have been studies concerning the pathogenesis, diagnosis and management of urinary tract infections, but various practices with the use of a large number of different antibiotics for varying durations were found. 1 A costeffective approach in this group of patients can be expected to maintain a high standard of care while conserving resources that may be better spent elsewhere.
In many clinical settings, patients presumed to have lower urinary tract infection, with compatible symptoms like dysuria, frequency and a positive dipstick test, are treated empirically without a prior urine culture. It has been observed that the specific combination of symptoms of dysuria and frequency in the absence of vaginal discharge achieved a probability of >90% in diagnosing cystitis. 2 The dipstick method in urinary tract infections with either leukocyte esterase or nitrite testing yielded a sensitivity of 75% and a specificity of 82%. 3 It is cheaper, faster and more convenient than the traditional urine culture analysis, and permits a presumptive confirmation of urinary tract infection for treatment without the expense and delays associated with urine culture. Reviews showed that obtaining an initial urine culture in all patients reduced expected symptom-days by about 10% but increased expected cost by about 40%, so it is reasonable not to obtain pre-treatment culture in presumed uncomplicated cystitis. 4 There have been great changes in the management of uncomplicated cystitis recently. As revealed in the United States and Hong Kong data, 75-90% of acute uncomplicated cystitis was caused by Escherichia coli (E. coli) and the rest by Klebsiella, Enterococci, Proteus, Staphylococcus and saprophytes. 5, 6 Trimethoprimsulfamethoxazole (co-trimoxazole), nitrofurantoin or ampicillin were commonly used as first line antibiotics, whereas the more expensive fluoroquinolones were second line drugs. However, there was an increasing trend in the prevalence of resistance among E. coli and all isolates to co-trimoxazole and ampicillin while less than 5% isolates was resistant to nitrofurantoin and quinolones. 5, 6 Therefore, nitrofurantoin became the more favourable option for empirical therapy. In recent years, different regimens were also compared. Three-day antibiotic regimens have been shown to be as effective as 7 to 10-day conventional regimens and were associated with fewer adverse effects, better compliance and lower cost. 1, 4, 7, 8 Routine follow up including urine culture was generally unnecessary after treatment for cystitis. Incidence of symptomatic urinary tract infection after therapy for acute cystitis was not reduced when routine follow up culture was used compared with culture only in symptomatic patients. 8 Clinical guidelines have been proposed as one strategy to reduce practice variability, control health care costs and improve patient outcomes. The Group Health Cooperative, a large non-profit health organisation in the United States, developed its practice guideline for presumed acute uncomplicated cystitis in women aged 18-55 years for 3-day antibiotics and proved that it could significantly reduce laboratory tests and overall costs while maintaining the quality of care for these patients. 9 We, in the AED of the Caritas Medical Centre, also promoted the use of short course antibiotics for presumed uncomplicated lower urinary tract infection in women with reference to the latest core manual of The Hong Kong Society for Emergency Medicine and Surgery. 10 In order to assess the outcome, a telephone survey was launched.
Patients and methods
It was a prospective outcome study to observe the clinical response, adverse effect and compliance of 3-day antibiotic treatment in presumed acute uncomplicated lower urinary tract infection in women attending our department from January to June 2004. This study had been approved by the C l i n i c a l Re s e a rc h Et h i c s C o m m i t t e e o f t h e Kowloon West Cluster.
Women aged between 18 to 55 years presenting to the AED were eligible for enrollment if they had symptoms of lower urinary tract infection including dysuria, frequency and no vaginal discharge, and/or haematuria with positive urine dipstick test. Women were excluded if they were pregnant, menstruating or nursing home residents; had evidence of upper urinary tract infection like fever, chills, and loin pain; history of anatomical or functional anomalies such as polycystic kidneys, stone, neurogenic bladder; previous renal surgery; comorbid conditions such as diabetes mellitus or immunocompromisation; and complicating factors like prolonged symptoms >14 days, previous pyelonephritis or antibiotic use in the recent month. 9 The doctor-in-charge explained the diagnosis and the study to eligible patients with a written note, and then obtain verbal consents before entering the data on the questionnaires, which were then collected by the first author for the telephone survey two weeks afterwards. They were discharged with empirical first line treatment of 3-day nitrofurantoin 100 mg four times a day, or second line ciprofloxacin 250 mg twice daily for those with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency or nitrofurantoin allergy, in addition to the pain-relieving pyridium, advice on perineal hygiene and increase of fluid intake.
The diagnosis of presumed uncomplicated cystitis was established with symptoms of dysuria, frequency in the absence of vaginal discharge and/or with urgency, haematuria, and positive leukocyte esterase or nitrite test. The outcome was assessed in three parts: the clinical response, adverse effect and compliance. Cure was defined as resolution of symptoms after the treatment, whereas failure included persistent symptoms or recurrence within two weeks of treatment re q u i r i n g a n o t h e r m e d i c a l c o n s u l t a t i o n o r reattendance. Nitrofurantoin was known to cause gastrointestinal side effects, and rarely haemolysis, peripheral neuropathy and allergic rash. Compliance was evaluated by the completion of the 3-day treatment.
Results
There were 83 women recruited in the study initially, but only 79 patients could be followed either by telephone survey or the computerised system in hospitals under the Hospital Authority.
Characteristics
The peak of cystitis lay in the reproductive age, and 60-70% patients got risk factors with sexual activity in the recent week or a previous history of urinary tract infection. The characteristics of all the patients are summarised in Tables 1 and 2 . 
Symptoms
More than half of the patients presented to the AED with one day history of symptoms and the majority attended within three days. More than 70% of patients complained of gross haematuria in addition to dysuria, and more than 90% got microscopic haematuria (Table 3) .
Treatment regimen
In the 83 patients, 82 were discharged with nitrofurantoin. Only one patient with G6PD deficiency was given ciprofloxacin according to the protocol. She attained clinical resolution after the course with no reported side effect and her result was counted in the success group. 
Outcome
Clinical response (Figure 1 ) There were 58 patients with good response to the 3-day therapy. In the remaining 21 patients, 16 were found to be failure in the phone survey, 2 reattended CMS=Clinical Management System in computer; S/S=symptoms & signs the AED or the outpatient clinic as noted in the computer system, and 3 changed to another drug after one day of antibiotic because of side effects and persistent symptoms.
In the 76 patients who followed the protocol with the use of 3-day antibiotic, 76.3% (58/76) got symptom relief, but 23.7% (18/76) failed with 17 complaining of persistent symptoms and 1 recurrence. For those cured, 77.6% (45/58) experienced symptom resolution on day 2. In the phone survey, all the 16 failed patients had persistent dysuria and less than half had persistent haematuria. All the failure cases resulted in another medical consultation, the majority (17/18) of them responded to one week of antibiotics, nitrofurantoin or other drugs, but one patient had persistent dysuria after a full course and was referred to the surgical clinic for further management.
Adverse effects
Seventy-seven patients participated in the phone survey, and 48.1% (37/77) reported adverse effects from nitrofurantoin. As expected, gastrointestinal symptoms accounted for the majority with nausea in 75.7%, vomiting in 16.2%, and the rest included headache, dizziness and bloating (Table 4) . None of them experienced peripheral neuropathy or abnormal bleeding. Only 2 out of the 37 patients could not tolerate the gastrointestinal effects and changed to other drugs after one day of nitrofurantoin.
Compliance
In the group with cure, 10 out of the 58 did not complete the 3-day course. One patient with treatment failure took only 2-day nitrofurantoin and experienced recurrence of symptoms on day 8. As mentioned previously, 2 patients changed to other drugs because of adverse effects, and
Discussion
According to Chan's study and statistics in the Department of Health, E. coli contributed to >80% of all urinary tract infections and its resistance was 30-40% for co-trimoxazole and 40-60% for ampicillin, similar to the pattern seen in the United States. 5, 6 Furthermore, the increasing linear trend in the prevalence of resistance among E. coli and other isolates was statistically significant for co-trimoxazole and ampicillin. 5 These data suggested that co-trimoxazole and ampicillin which were commonly used as first line regimens might not be acceptable choices for empirical treatment any longer. However, nitrofurantoin and ciprofloxacin remain highly active against E. coli and most non-E. coli isolates. This makes nitrofurantoin a reasonable option for empirical therapy and ciprofloxacin as the second line drug because of its cost and the concern of resistance with increasing use.
Hooten et al conducted a research on 3-day antibiotic therapy in 1995 in the United States with 61% cure rate. 7 However, a better success rate of 76.3% was seen in this study. It is suggested that the better response might be related to different susceptibilities in different geographic locations. Concerning the adverse effects from nitrofurantoin, the reported proportions were similar -48% in this study and 43% in Hooten's. The outcomes in the two studies are compared in Table 5 .
In this study, 3-day nitrofurantoin attained an acceptable clinical response of 76%, and a good compliance rate above 80%. Most of the patients with initial failure could get symptom resolution when they To lower the adverse effects, antacid or histamine-2 blocker can be prescribed in addition since some patients had good response as revealed in the survey. Explanation of the known side effects upon discharge can also help to improve compliance. Twice daily nitrofurantoin monohydrate macrocrystal is a simpler and more convenient regimen with less gastrointestinal side effects, but it was not available in our hospital.
After all, 75 out of 76 patients (99%) responded to 3-to 7-day antibiotic treatment and only 1% of patients required specialist referral. We can safely discharge and advise the patients to return if symptoms persist, to continue for a 7-day course, which will in turn relieve the workload of the department's follow up clinic. For those with persistent failure, urine culture and further follow up are needed to treat accordingly and referral to specialists for investigation should be considered. Figure 2 is a suggested protocol for the management of uncomplicated cystitis in females in the AED.
Collected from local data, a 3-day course of nitrofurantoin costs HK$2.38, co-trimoxazole HK$5.81, ciprofloxacin HK$25.8. Therefore, nitrofurantoin is recommended as the first line therapy in view of its good E. coli susceptibility and economic attribute. 
Conclusion
Concerning cost-effectiveness in the treatment of presumed acute uncomplicated cystitis in women, 3-day nitrofurantoin is suggested as an empirical therapy with acceptable clinical response and good compliance. In order to improve the cure rate, longer treatment durations like a 5-day course need to be studied, but compliance, associated adverse effects and expense are important considerations. 1 Guidelines on the management of uncomplicated cystitis are also advocated in this study. Firstly, the diagnosis of this common problem can be reached quickly with specific combinations of symptoms and urine dipstick tests. A more standardised use of effective antibiotics in less costly treatment r e g i m e n s f o r t h e l a r g e n u m b e r o f p a t i e n t s encountered in the AED can conserve health care costs, improve compliance and reduce resistance development.
